The work after a result.

A molecular result is available. The work is not finished.

Authorized teams review variant evidence, compare protocol criteria, prepare billing documentation, and record decisions for later review.

That work determines whether a result reaches an accountable next step.

Sequencing and analytical tools continue to improve, but the handoffs after a result remain fragmented.

A molecular result may need evidence review, protocol comparison, billing documentation, and follow-up across different teams. Each team needs the source record, applied criteria, and current review status. Those handoffs often span disconnected systems.

The structural absence

Organizations repeatedly implement similar workflow logic for evidence review, protocol pre-screening, billing routing, and compliance documentation.

The science advances. The execution repeats.

This is the central problem. Many programs still lack a shared execution layer for this work.